McKesson consensus stays solid, analysts see upside for shares
23.06.2026 - 17:39:59 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 17:39.
McKesson Corporation (US58155Q1031) sits firmly in the US healthcare sector with its shares listed on the NYSE under the ticker MCK. Ahead of the next earnings season, the stock shows a clear analyst consensus picture with a moderate buy stance and double-digit upside potential from current levels.
What the consensus says
According to data compiled by MarketBeat from several Wall Street firms, McKesson carries an average analyst rating of "Moderate Buy" and an average target price around 960.53 dollars, above the latest trading print. The NYSE-listed shares most recently opened at about 745.12 dollars on Tuesday, implying roughly 29 percent upside to that average target. The 52-week range runs from 637.00 dollars on the downside to a high of 999.00 dollars, signaling that the consensus target is anchored close to the upper end of the historic band. The stock's 50-day moving average stands at 785.38 dollars, while the 200-day moving average is higher at 841.72 dollars, describing a period of consolidation below longer-term trend levels. One of the more recent house views comes from Deutsche Bank Aktiengesellschaft, which reiterates a buy rating and sets its price objective at 875 dollars in a research note published in early May. This Deutsche Bank target, while below the broader consensus, still points to high single-digit upside from Tuesday's opening price and underpins the moderate buy consensus. MarketBeat analyst summary on McKesson
How investors position in McKesson
The analyst picture is complemented by positioning changes in institutional portfolios. Generate Investment Management Ltd reduced its stake in McKesson by 85.7 percent in the first quarter, according to a fresh 13F filing disclosed by the SEC and summarized by MarketBeat on June 23. After this reduction, the position now represents a smaller fraction of the fund's assets, but McKesson continues to feature alongside other large-cap healthcare names such as AmerisourceBergen and Cardinal Health in many sector portfolios. McKesson itself operates with a substantial market capitalization, estimated in the tens of billions of dollars, which keeps the stock relevant for major US benchmarks and sector indices, even though it is not part of the S&P 500 healthcare distributors sub-index in a narrow sense. For retail investors, these institutional flows and analyst views provide a data-backed frame when they compare McKesson with peers like Cardinal Health and AmerisourceBergen in the US distribution space. MarketBeat report on Generate Investment Management's McKesson filing
Background and price data on McKesson
More news, filings and historical price data help investors put the McKesson shares into a broader long-term context.
The business behind McKesson
McKesson generates its revenue primarily by distributing branded and generic pharmaceuticals, medical-surgical supplies and related healthcare products across North America and parts of Europe. The company also offers technology solutions for pharmacies, hospitals and health systems, including inventory management, logistics software and data analytics aimed at improving efficiency and patient outcomes. In June 2026, McKesson highlighted a strategic investment with Apollo funds involving a minority interest in its Medical-Surgical Solutions unit, reinforcing the importance of this product line in its portfolio. The medical-surgical segment covers everything from syringes and gloves to operating room supplies, giving the company a broad base of recurring demand across hospitals and clinics. These operations position McKesson alongside peers like Cardinal Health and Owens & Minor in the medical distribution and supplies market, with scale advantages that support stable cash flows. McKesson IR release on the Apollo investment in Medical-Surgical Solutions
Where the McKesson shares trade today
McKesson shares (US58155Q1031) trade on the NYSE under the symbol MCK and most recently opened at 745.12 dollars on Tuesday, June 23, 2026. This level places the stock below both its 50-day moving average of 785.38 dollars and its 200-day moving average of 841.72 dollars as of the same date.
Key data on the McKesson shares
- Company: McKesson Corporation
- ISIN: US58155Q1031
- WKN: 919558
- Ticker: MCK
- Trading venue: NYSE
- Price (as of 2026-06-23, 10:37): 745.12 USD
- Market cap: approximately 60 billion USD (as of 2026-06-23)
- Sector / industry: Healthcare distribution and services
- Index membership: major US healthcare sector indices, NYSE listing
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. All data are based on sources deemed reliable but cannot be guaranteed for accuracy or completeness.
